Newel Health’s Post

📊 Exciting developments in #CellandGeneTherapy! Today, the BIA, in collaboration with Citeline released a comprehensive report highlighting the UK's global leadership in the sector. From record VC funding to clinical trial leadership, discover how the UK is shaping the future of #Healthcare 🏥 💡 Dive into the insights and witness the transformative impact on patient lives 🚀 ➡️ https://ow.ly/K3ss50Qs0QF #CellandGeneUK

#CEODesk 🖊️ Revolutionizing Healthcare: TruDoc's Acquisition Marks a Transformative Era TruDoc Healthcare's acquisition of Wellthy Therapeutics heralds a transformative era in tech-enabled primary care. This merger isn't just a union of two entities but a synergy of vision -a vision that intrinsically values the confluence of behavioural science with proactive healthcare management to revolutionize patient outcomes and healthcare expenditure. Transforming Healthcare Delivery: 🌐 Seamless Integration of Expertise: This alliance is set to redefine healthcare paradigms, merging Wellthy's behavioural science with TruDoc's 24/7 healthcare services, pivoting the industry towards a new era of tech-forward, patient-centred care. 🌐 Patient-Centric Focus: At the core of this partnership lies a profound commitment to patient-centred healthcare, promising an integrated and comprehensive care ecosystem that not only treats but also empowers patients. 🌐 Strategic Regional Expansion: The partnership fortifies TruDoc's stronghold in the GCC and leverages Wellthy's Asian market prowess to architect a robust and expansive healthcare framework. Market Implications: This merger is a strong indicator of the impending disruption in the healthcare sector, spotlighting the ascendancy of digital health solutions intertwined with clinical expertise. The ramifications are promising, earmarking a steep curve in healthcare delivery evolution, particularly in the GCC and Asia. Investment Insights: 💡Embrace Innovation: Company mergers like TruDoc and Wellthy spotlight the lucrative potential in digital health and tech-based care solutions. 💡Eye Regional Expansion: This partnership amplifies the investment appeal in the blossoming healthcare sectors of the GCC and Asia. 💡Sustainable Impact: Their ambitious goal to touch 10 million lives elucidates the investment allure in sustainable and patient-impact-focused health solutions. With the industry on the cusp of such pivotal transformation, how do we, as innovators and investors, fortify our strategies to harmonize with this novel patient-centric, tech-enabled healthcare landscape? For profound industry insights and to engage in strategic dialogue, follow #MarketUnwinded for more. Read More: https://lnkd.in/eEMpzWFx #TruDocHealthcare #WellthyTherapeutics #HealthcareRevolution #PatientCareInnovation #DigitalHealth #GCC #Asia #StrategicPartnership #HealthTechInvestment

🌟 Appreciation Post Alert! 🌟 Feeling grateful for my incredible circle of friends who are making significant impacts across various sectors. Today, I'm thrilled to highlight Emmanuel Akpakwu, the dynamic CEO of Axmed. 🎉 Why celebrate Emmanuel? His venture, Axmed, just secured a remarkable $2 million funding round, building on a $5 million grant from the Bill & Melinda Gates Foundation. 🔍 What challenge does Axmed tackle? Despite representing over 80% of the global population and bearing more than 90% of the world's disease burden, low- and middle-income countries see account for a mere 6% of global pharmaceutical revenues. This disparity stems from structural and commercial biases favouring rich economies. 🌍 How does Axmed plan to solve this? By offering a platform where governments and organisations from emerging nations can consolidate their drug orders. This aggregation creates large-scale demand, enticing manufacturers to supply essential medications at prices these countries can afford. Here's to Emmanuel and Axmed, bridging gaps and fostering health equity! 🌐✨ Below is an article from Forbes summarising Emmanuel and Axmed's milestone. https://lnkd.in/eA9JNVTq

Check out our new case study!

We’re thrilled that our Founder & CEO, Michael Pace, will be moderating this timely HealthXL roundtable this week, w/ host Richard Bunney of Deviceology Ltd. While the sun may have set on some early pioneering prescription #digitaltherapeutics firms, legacies are being leveraged, learnings are being applied and the landscape is shifting in ways like never before, opening up new opportunity for the next generation of #PDT companies. We are very excited about the next phases of integration of #PDTs into standards of care and traditional #pharmacy and #medical benefits in the U.S. #digitalhealth #dtx #digital #health #medicaldevices #healthcare #pharmaceuticals #software #medicine

The Basel #Healthtech Conference is off to a great start, with timely discussions on healthcare innovation and interesting perspectives on both early and late-stage investments. We’re looking forward to connecting with and hearing more from industry leaders, investors, startup founders, and other key decision makers on what to expect in 2024 and beyond.    Be sure to say hello to our CFO Tzahi Sarousi who will be back tomorrow for day two of the conference!   #BaselHealthtech2024 #clinicaltrials #clinicalresearch #drugdevelopment #biometrics #CRO #datamanagement

At Syneos Health, our experts conceptualize and execute Time & Motion studies of any complexity to help unlock the value story of your asset. Reach out to Erwin De Cock to learn more. #SyneosHealth #realworldevidence

In January 2024, Natalie Koster and Dr. Carsten von Blohn von Blohn founded the Healthonauts, combining the best aspects of pharma consultancy and agency work, specifically targeting companies in the rare disease. Now, half a year into the foundation of the business, the founders Natalie Koster and Carsten von Blohn are taking stock:   ❓ Reflecting on the past six months, what key milestones and achievements have defined the Healthonauts’ journey? ✔ Carsten: Already in the first months, we won a pitch, and we think it’s due to our unique combination of competencies. At the moment, we work for nine clients, including orphan disease small companies and big pharma, covering not only existing projects from our respective networks but also several new clients. ✔ Natalie: Internally, we have aimed at and achieved transparent and structured ways of working together. Along with the team, we have defined our company values, feedback and learning processes, and we are still in the process of defining key workstreams.   ❓ Founding the Healthonauts, was there anything that you didn’t expect? ✔ Natalie: We had anticipated moving more slowly but were surprised by the steep uptake, so we decided to grow the team earlier than we had originally planned. ✔ Carsten: We were convinced of our goals when founding the Healthonauts but were surprised by the immediate positive feedback from our networks on the concept of “the best of two worlds.”   ❓ Can you share an anecdote from the founding phase? 😅 Natalie: We wanted to be really quick in setting up the company, so we chose a “neobank” for a company bank account. But it turned out that instead of the anticipated couple of days, the “neobank” needed several weeks to set up our account and did not respond to questions. So we turned to a traditional bank instead, which actually proved to be much quicker.   ❓ With a growing team of consultants who all work remotely, how do you keep the group spirit at the Healthonauts? ☕ Carsten: We set up structures and processes to meet and get familiar with each other. For example, we have a weekly coffee chat and we make a point of taking any opportunity to meet in person, e.g., in Hamburg, Berlin, Cologne, or wherever we have more than two Healthonauts in one place.   ❓ Are there any learnings that you would give someone else aiming to found a company? ✔ Natalie: My advice is not to underestimate the amount of time you need to spend on organizational tasks – that really eats into your workday! Plus, spend some effort on setting up your structure as this will save you time in the long run. ✔ Carsten: Founding a company is a “people business.” Typically, the strategic approach is strategy-structure-people. In founding a small consultancy business, you need a nucleus of dedicated people and build the business around that founding team.

At Syneos Health, our experts conceptualize and execute Time & Motion studies of any complexity to help unlock the value story of your asset. Reach out to learn more. #SyneosHealth